These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17669177)

  • 1. National policies for xenotransplantation in the USA.
    Bloom ET
    Xenotransplantation; 2007 Jul; 14(4):345-6. PubMed ID: 17669177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework.
    Cozzi E; Tallacchini M; Flanagan EB; Pierson RN; Sykes M; Vanderpool HY
    Xenotransplantation; 2009; 16(4):203-14. PubMed ID: 19799760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA seeks "comfort factors" before removing hold on porcine xenotransplantation trials.
    Fox JL
    Nat Biotechnol; 1998 Mar; 16(3):224. PubMed ID: 9527996
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes trial stirs debate on safety of xenotransplants.
    Check E
    Nature; 2002 Sep; 419(6902):5. PubMed ID: 12214198
    [No Abstract]   [Full Text] [Related]  

  • 5. New FDA xenotransplantation documents: a proposed rule and a draft guidance.
    Bloom ET
    Xenotransplantation; 2001 Aug; 8(3):153-4. PubMed ID: 11472622
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of xenogeneic porcine pancreatic islets.
    Arcidiacono JA; Evdokimov E; Lee MH; Jones J; Rudenko L; Schneider B; Snoy PJ; Wei CH; Wensky AK; Wonnacott K
    Xenotransplantation; 2010; 17(5):329-37. PubMed ID: 20955290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19-21 November 2008. The Changsha Communiqué.
    Xenotransplantation; 2009; 16(2):61-3. PubMed ID: 19392720
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 9. US decides close tabs must be kept on xenotransplants..
    Butler D
    Nature; 2000 Jun; 405(6787):606-7. PubMed ID: 10864296
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA warns on primate xenotransplants.
    Butler D
    Nature; 1999 Apr; 398(6728):549. PubMed ID: 10217130
    [No Abstract]   [Full Text] [Related]  

  • 11. Xenotransplantation--clinical activities and regulatory development.
    Tibell A; Lundgren T
    Acta Vet Scand Suppl; 2004; 99():19-23. PubMed ID: 15347142
    [No Abstract]   [Full Text] [Related]  

  • 12. Xenotransplantation--federal regulatory considerations.
    Bloom ET
    Curr Top Microbiol Immunol; 2003; 278():239-51. PubMed ID: 12934947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public have right to see data from all gene trials, says FDA.
    Smaglik P
    Nature; 2001 Jan; 409(6819):442. PubMed ID: 11206508
    [No Abstract]   [Full Text] [Related]  

  • 14. A shrewd and ethical approach to xenotransplantation.
    Bach FH; Ivinson AJ
    Trends Biotechnol; 2002 Mar; 20(3):129-31. PubMed ID: 11841865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenotransplantation: regulatory challenges.
    Bloom ET
    Curr Opin Biotechnol; 2001 Jun; 12(3):312-6. PubMed ID: 11404112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenotransplantation: a review of current issues.
    Greenstein JL; White-Scharf M
    J Biolaw Bus; 1998; 2(1):46-50. PubMed ID: 11657637
    [No Abstract]   [Full Text] [Related]  

  • 18. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 19. The US Public Health Service guideline for xenotransplantation: advances and limitations.
    Salomon DR
    Xenotransplantation; 2001 May; 8(2):86-9. PubMed ID: 11488261
    [No Abstract]   [Full Text] [Related]  

  • 20. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.